Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 1120, doi. 10.1111/dom.15385
- By:
- Publication type:
- Article
Works matching AU Alkabbani, Wajd
Results: 20
1
2
Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3490, doi. 10.1111/dom.15241
- By:
- Publication type:
- Article
3
Author's Reply to Kuss and Rathmann's Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".
- Published in:
- Drug Safety, 2023, v. 46, n. 5, p. 513, doi. 10.1007/s40264-023-01293-5
- By:
- Publication type:
- Article
4
Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.".
- Published in:
- Drug Safety, 2022, v. 45, n. 7, p. 813, doi. 10.1007/s40264-022-01192-1
- By:
- Publication type:
- Article
5
Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.
- Published in:
- Drug Safety, 2022, v. 45, n. 3, p. 287, doi. 10.1007/s40264-022-01166-3
- By:
- Publication type:
- Article
6
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study.
- Published in:
- Diabetes Care, 2023, v. 46, n. 8, p. 1492, doi. 10.2337/dc23-0222
- By:
- Publication type:
- Article
7
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study.
- Published in:
- Diabetes Care, 2023, v. 46, n. 2, p. 331, doi. 10.2337/dc22-1496
- By:
- Publication type:
- Article
8
Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 8, p. 1, doi. 10.1111/dme.14858
- By:
- Publication type:
- Article
9
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 3057, doi. 10.2147/DDDT.S281602
- By:
- Publication type:
- Article
10
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population‐based cohort study.
- Published in:
- Addiction, 2019, v. 114, n. 10, p. 1791, doi. 10.1111/add.14719
- By:
- Publication type:
- Article
11
Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events.
- Published in:
- American Journal of Epidemiology, 2021, v. 190, n. 8, p. 1572, doi. 10.1093/aje/kwab052
- By:
- Publication type:
- Article
12
Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 431, doi. 10.1111/bcp.15178
- By:
- Publication type:
- Article
13
Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling.
- Published in:
- International Journal of Epidemiology, 2023, v. 52, n. 3, p. 908, doi. 10.1093/ije/dyac168
- By:
- Publication type:
- Article
14
Use of Potentially Inappropriate Medications among Older Adults with Dementia or Cognitive Impairment Attending Memory Clinics: A Protocol for a Systematic Review and Meta-Analysis.
- Published in:
- Biomedicine Hub, 2024, v. 9, n. 1, p. 1, doi. 10.1159/000539074
- By:
- Publication type:
- Article
15
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews.
- Published in:
- Therapeutic Advances in Drug Safety, 2021, v. 12, p. 1, doi. 10.1177/2042098621989134
- By:
- Publication type:
- Article
16
Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada.
- Published in:
- Journal of Pharmaceutical Health Services Research, 2023, v. 14, n. 2, p. 99, doi. 10.1093/jphsr/rmad023
- By:
- Publication type:
- Article
17
The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2020, v. 3, n. 3, p. 1, doi. 10.1002/edm2.145
- By:
- Publication type:
- Article
18
Cannabis is legal—why are cannabis-based pharmaceuticals still controlled?
- Published in:
- Canadian Pharmacists Journal, 2020, v. 153, n. 6, p. 323, doi. 10.1177/1715163520960500
- By:
- Publication type:
- Article
19
Use of Potentially Inappropriate Medication Among Older Adults with Dementia or/and Cognitive Impairment Attending Memory Clinics: a Systematic Review and Meta-Analysis.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
20
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study.
- Published in:
- CMAJ Open, 2018, v. 6, n. 4, p. E637, doi. 10.9778/cmajo.20180109
- By:
- Publication type:
- Article